SMTL ID : 6o8d.1

Anti-CD28xCD3 CODV Fab bound to CD28

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.55 Å

Oligo State

hetero-2-2-2-mer

Ligands

2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: L.4, E.108, N.111 Chain D: L.41, D.42 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 5 residues within 4Å: Chain A: L.41, D.42 Chain D: L.4, E.108, N.111 No protein-ligand interaction detected (PLIP)

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain A: V.86, N.87 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:V.86 NAG.4: 2 residues within 4Å: Chain D: V.86, N.87 1 PLIP interactions: 1 interactions with chain D Hydrophobic interactions: D:V.86

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wu, L. et al., Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation. To Be Published

Release Date

2019-11-20

Peptides

T-cell-specific surface glycoprotein CD28: AD
Anti-CD28xCD3 CODV Fab Light chain: BE
Anti-CD28xCD3 CODV Fab Heavy chain: CF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

D
C

B
L

E
L

C
H

F
H

T-cell-specific surface glycoprotein CD28

Anti-CD28xCD3 CODV Fab Light chain

Anti-CD28xCD3 CODV Fab Heavy chain

Related Entries With Identical Sequence